Lupkynis

Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook
Investors Business Daily
Thu, 03/3/22 - 11:36 pm
Aurinia Pharmaceuticals
earnings
Lupkynis
As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions
Fierce Pharma
Thu, 06/24/21 - 11:11 am
GSK
Aurinia
lupus nephritis
Benlysta
Lupkynis
FDA
Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Fierce Pharma
Mon, 02/22/21 - 10:46 am
Catalent
Aurinia Pharmaceuticals
lupus nephritis
Lupkynis
CDMOs
Here’s Why the Approval of Lupkynis Has Biotech Investors Buzzing
Xtalks
Mon, 02/1/21 - 10:52 am
FDA
Aurinia Pharmaceuticals
Lupkynis
voclosporin
lupus nephritis
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
Thu, 01/28/21 - 10:49 am
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch
Fierce Pharma
Sat, 01/23/21 - 11:46 pm
Aurinia
FDA
Lupkynis
voclosporin
lupus nephritis